NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 431,900 | $15,613 | 0.02% |
| DARK FOREST CAPITAL MANAGEMENT LP | 2,219 | $80,217 | 0.02% |
| Leucadia National | 60,000 | $2,169,000 | 0.02% |
| PRINCIPAL FINANCIAL GROUP INC | 649,956 | $23,495,910 | 0.02% |
| ExodusPoint Capital Management, LP | 58,340 | $2,109 | 0.02% |
| Trexquant Investment LP | 16,617 | $600,705 | 0.02% |
| FMR LLC | 9,001,794 | $325,414,852 | 0.02% |
| Squarepoint Ops LLC | 90,761 | $3,281,010 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 638,974 | $23,099 | 0.01% |
| CREDIT SUISSE AG/ | 350,215 | $12,660,273 | 0.01% |
| Invesco Ltd. | 1,050,809 | $37,986,745 | 0.01% |
| ETF MANAGERS GROUP, LLC | 8,198 | $296,358 | 0.01% |
| Man Group plc | 79,852 | $2,886,650 | 0.01% |
| Leucadia National | 33,218 | $1,200,831 | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 53,539 | $1,935,435 | 0.01% |
| Bridgewater Associates | 42,501 | $1,536,411 | 0.01% |
| MARSHALL WACE, LLP | 109,381 | $3,954,123 | 0.01% |
| Schonfeld Strategic Advisors LLC | 23,926 | $864,924 | 0.01% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 14,871 | $537,587 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 142,038 | $5,134 | 0.01% |
External links
This page lists NEVRO CORP's shareholders in Q1 2023. To view NEVRO CORP's shareholder history, click here.